NO20054767L - Sammensetninger omfattende apomorfin for inhalering i lunge - Google Patents
Sammensetninger omfattende apomorfin for inhalering i lungeInfo
- Publication number
- NO20054767L NO20054767L NO20054767A NO20054767A NO20054767L NO 20054767 L NO20054767 L NO 20054767L NO 20054767 A NO20054767 A NO 20054767A NO 20054767 A NO20054767 A NO 20054767A NO 20054767 L NO20054767 L NO 20054767L
- Authority
- NO
- Norway
- Prior art keywords
- apomorphine
- formulations
- compositions
- present
- sexual dysfunction
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 title abstract 4
- 229960004046 apomorphine Drugs 0.000 title abstract 4
- 210000004072 lung Anatomy 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 4
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 3
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/413,022 US20040204439A1 (en) | 2003-04-14 | 2003-04-14 | Composition, device, and method for treating sexual dysfunction via inhalation |
| US10/621,964 US20040204440A1 (en) | 2003-04-14 | 2003-07-17 | Composition, device, and method for treating sexual dysfunction via inhalation |
| PCT/GB2004/001627 WO2004089374A1 (en) | 2003-04-14 | 2004-04-14 | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054767D0 NO20054767D0 (no) | 2005-10-17 |
| NO20054767L true NO20054767L (no) | 2005-12-21 |
Family
ID=33161980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054767A NO20054767L (no) | 2003-04-14 | 2005-10-17 | Sammensetninger omfattende apomorfin for inhalering i lunge |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060178394A1 (pt) |
| EP (1) | EP1613323A1 (pt) |
| JP (1) | JP2006522785A (pt) |
| AU (1) | AU2004228757A1 (pt) |
| BR (1) | BRPI0409380A (pt) |
| CA (1) | CA2522231A1 (pt) |
| NO (1) | NO20054767L (pt) |
| RU (1) | RU2364400C2 (pt) |
| WO (1) | WO2004089374A1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0321607D0 (en) | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
| MX2007011976A (es) * | 2005-03-28 | 2007-12-07 | Orexo Ab | Composiciones farmaceuticas novedosas utiles en el tratamiento de la enfermedad de parkinson. |
| GB0721394D0 (en) * | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
| JP2012524815A (ja) * | 2009-04-24 | 2012-10-18 | シェーリング コーポレイション | 乾燥粉末吸引器において有用な凝集体配合物 |
| TW201304822A (zh) * | 2010-11-15 | 2013-02-01 | Vectura Ltd | 組成物及用途 |
| EP3313394A4 (en) * | 2015-06-23 | 2019-02-27 | Axim Biotechnologies, Inc. | ANTIMICROBIAL COMPOSITIONS WITH CANNABINOIDS |
| US20170071248A1 (en) * | 2015-09-16 | 2017-03-16 | Sansa Corporation (Barbados) Inc. | System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations |
| US11224594B2 (en) | 2015-09-16 | 2022-01-18 | Philip Morris Products S.A. | Nicotine formulations and methods of making and using the same |
| ES2988939T3 (es) | 2016-07-08 | 2024-11-22 | Trudell Medical Int Inc | Dispositivo de presión espiratoria positiva oscilante inteligente |
| CN110049795B (zh) | 2016-12-09 | 2022-07-19 | 特鲁德尔医学国际公司 | 智能雾化器 |
| US11666801B2 (en) | 2018-01-04 | 2023-06-06 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
| WO2021038467A1 (en) | 2019-08-27 | 2021-03-04 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
| GB201912686D0 (en) * | 2019-09-04 | 2019-10-16 | Reown Pharma Inc | Pharmaceutical composition |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4080456A (en) * | 1971-10-26 | 1978-03-21 | Schering Aktiengesellschaft | Diacylapomorphines |
| US4687773A (en) * | 1983-03-28 | 1987-08-18 | Mclean Hospital | (+)-N-N-propylnorapomorphine and selective limbic activity |
| US4521421A (en) * | 1983-09-26 | 1985-06-04 | Eli Lilly And Company | Treatment of sexual dysfunction |
| US5292520A (en) * | 1990-09-13 | 1994-03-08 | Akzo N.V. | Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer |
| US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| ATE290864T1 (de) * | 1993-03-26 | 2005-04-15 | Franciscus Wilhelmus He Merkus | Pharmazeutische zusammensetzungen zur intranasalen verabreichung von dihydroergotamin |
| US6395744B1 (en) * | 1994-04-22 | 2002-05-28 | Queen's University At Kingston | Method and compositions for the treatment or amelioration of female sexual dysfunction |
| US6566368B2 (en) * | 1994-04-22 | 2003-05-20 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
| WO1995028930A1 (en) * | 1994-04-22 | 1995-11-02 | Pentech Pharmaceuticals, Inc. | Dosage forms and method for ameliorating male erectile dysfunction |
| US6121276A (en) * | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| US20020165122A1 (en) * | 1994-04-22 | 2002-11-07 | Heaton Jeremy P. W. | Method and compositions for the treatment or amelioration of female sexual dysfunction |
| US5699789A (en) * | 1996-03-11 | 1997-12-23 | Hendricks; Mark R. | Dry powder inhaler |
| GB9606677D0 (en) * | 1996-03-29 | 1996-06-05 | Glaxo Wellcome Inc | Process and device |
| CA2277801C (en) * | 1997-01-16 | 2002-10-15 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| DE69831421T2 (de) * | 1997-12-02 | 2006-06-22 | Archimedes Development Ltd. | Zusammensetzungen zur nasalen verabreichung |
| US5945117A (en) * | 1998-01-30 | 1999-08-31 | Pentech Pharmaceuticals, Inc. | Treatment of female sexual dysfunction |
| US6403605B1 (en) * | 1998-05-29 | 2002-06-11 | Queen's University At Kingston | Methods for the normalization of sexual response and amelioration of long term genital tissue degradation |
| US6200591B1 (en) * | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
| US20020002175A1 (en) * | 2000-09-19 | 2002-01-03 | Charanjit Behl | Nasal delivery of apomorphine in combination with glycol derivatives |
| US6436950B1 (en) * | 1998-08-14 | 2002-08-20 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of apomorphine |
| US5994363A (en) * | 1998-08-24 | 1999-11-30 | Pentech Pharmaceuticals, Inc. | Amelioration of apomorphine adverse effects |
| IT1303788B1 (it) * | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
| GB9827145D0 (en) * | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
| US7074388B2 (en) * | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
| US6291471B1 (en) * | 1998-12-17 | 2001-09-18 | Abb Holdings, Inc. | Use of apomorphine for the treatment of organic erectile dysfunction in males |
| EP1180021A4 (en) * | 1999-05-06 | 2005-01-19 | Pentech Pharmaceuticals Inc | TREATMENT OF THE PREMATURE EJACULATION AND ASSOCIATED KIT |
| US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| JP2001151673A (ja) * | 1999-09-06 | 2001-06-05 | Nikken Chem Co Ltd | 吸入用粉末製剤の製造方法 |
| JP2001072586A (ja) * | 1999-09-06 | 2001-03-21 | Nikken Chem Co Ltd | 吸入用粉末製剤及びその製造方法 |
| BR0005797A (pt) * | 2000-03-20 | 2001-10-16 | Abbott Lab | Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados |
| MXPA02009904A (es) * | 2000-04-07 | 2004-09-06 | Tap Pharmaceutical Prod Inc | Derivados de apomorfina y metodos para su uso. |
| US6948494B1 (en) * | 2000-05-10 | 2005-09-27 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet and method of use |
| US6514482B1 (en) * | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| PL361875A1 (en) * | 2000-11-15 | 2004-10-04 | Tap Pharmaceutical Products, Inc. | Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| US20020086876A1 (en) * | 2000-11-15 | 2002-07-04 | Ruff Dustin D. | Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| JP2002184831A (ja) * | 2000-12-11 | 2002-06-28 | Hirata Corp | Ｆｏｕｐオープナ |
| JP2005503425A (ja) * | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | 所定の吸入ルートによる薬剤エステルの送出 |
| WO2003026631A1 (en) * | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
-
2004
- 2004-04-14 CA CA002522231A patent/CA2522231A1/en not_active Abandoned
- 2004-04-14 JP JP2006506129A patent/JP2006522785A/ja active Pending
- 2004-04-14 RU RU2005135133/15A patent/RU2364400C2/ru not_active IP Right Cessation
- 2004-04-14 US US10/552,231 patent/US20060178394A1/en not_active Abandoned
- 2004-04-14 BR BRPI0409380-1A patent/BRPI0409380A/pt not_active IP Right Cessation
- 2004-04-14 AU AU2004228757A patent/AU2004228757A1/en not_active Abandoned
- 2004-04-14 EP EP04727312A patent/EP1613323A1/en not_active Withdrawn
- 2004-04-14 WO PCT/GB2004/001627 patent/WO2004089374A1/en not_active Ceased
-
2005
- 2005-10-17 NO NO20054767A patent/NO20054767L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2364400C2 (ru) | 2009-08-20 |
| AU2004228757A1 (en) | 2004-10-21 |
| JP2006522785A (ja) | 2006-10-05 |
| BRPI0409380A (pt) | 2006-04-18 |
| EP1613323A1 (en) | 2006-01-11 |
| US20060178394A1 (en) | 2006-08-10 |
| NO20054767D0 (no) | 2005-10-17 |
| CA2522231A1 (en) | 2004-10-21 |
| RU2005135133A (ru) | 2006-06-10 |
| WO2004089374A1 (en) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG169233A1 (en) | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation | |
| WO2008151235A3 (en) | Compositions for delivering medicaments into the lungs, uses thereof | |
| NO20054767L (no) | Sammensetninger omfattende apomorfin for inhalering i lunge | |
| WO2008022189A3 (en) | Administration of high potency platinum compound formulations by inhalation | |
| SG146649A1 (en) | Mucoactive agents for treating a pulmonary disease | |
| SE0201669D0 (sv) | New formulation and use thereof | |
| MEP30108A (en) | Formoterol superfine formulation | |
| UY26959A1 (es) | Nuevos polvos para inhalación que contienen tiotropio | |
| EA200702387A1 (ru) | Имидазохинолины в качестве ингибиторов липидкиназы | |
| EA201100305A1 (ru) | Лечение респираторных заболеваний | |
| UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
| WO2010068754A3 (en) | Methods and compositions for delivery of medicaments to the lungs | |
| NO20032111L (no) | Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter | |
| NO20063693L (no) | Forbindelse og metode for anvendelse | |
| ATE330589T1 (de) | Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege | |
| MX2007004495A (es) | Composiciones y procedimientos para la administracion intranasal, bucal, sublingual y pulmonar de vareniclina. | |
| NZ587561A (en) | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations (an muscarinic antagnoist) | |
| MX2010002498A (es) | Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol. | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| UA98136C2 (ru) | Применение аклидиния для лечения респираторных заболеваний | |
| NO20063047L (no) | Vandige ciclesonidsuspensjoner for forstoving | |
| EA200600854A1 (ru) | Новые соли тиотропия, способ их получения, а также содержащие их лекарственные композиции | |
| TW200604196A (en) | New quinuclidine derivatives and pharmaceutical compositions comprising them | |
| SE0400378D0 (sv) | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet | |
| MY143364A (en) | Method for producing tiotropium salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |